Jula Inrig
CHIEF MEDICAL OFFICER; EVP, Head of R&D & CMO · 6 filings · Latest: Sep 15, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | JULA INRIG | — | Dec 24, 2025 | Proposed Sale | $42.00 | 15,000 | $630.0K | — | |
TVTX | Jula Inrig | — | Feb 12, 2025 | Proposed Sale | $23.53 | 2,568 | $60.4K | — | |
TVTX | JULA INRIG | — | Feb 4, 2025 | Proposed Sale | $20.11 | 1,066 | $21.4K | — | |
TVTX | Jula Inrig | — | Feb 3, 2025 | Proposed Sale | $20.12 | 4,207 | $84.6K | — |
← Previous
Page 2 of 2